Most of the genetic risk for developing a substance use disorder comes from genes that broadly affect how our brains process ...

Researchers analyze 2.2 million genomes to show that addiction risk is primarily driven by broad genes affecting brain wiring and impulse control, not drug-specific traits.

RESEDA, CA - March 19, 2026 - PRESSADVANTAGE - Moment of Clarity has published a comprehensive new educational resource ...

Public event to feature real recovery stories and launch new Journeys and Child Watch programs removing barriers to ...

Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second generation, ...

Background Alcohol use disorder and treatment-resistant depression (TRD) often co-occur, presenting a major clinical challenge with limited effective treatments. However, ketamine produces rapid ...

Understanding what the US spends to treat mental health and substance use disorders (SUD) is important for understanding spending patterns and informing health policy. In this study, we determined ...

The ACLU is suing the state of West Virginia for its moratorium on methadone clinics, a practice that cuts the risk of ...

Alcohol use disorder (AUD) remains a major public health challenge in the United States, contributing to more than 170,000 ...

Marijuana doesn’t help with anxiety, PTSD, depression or other mental health conditions, according to two large, new studies.

Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder, affecting 12%–13% of adolescents in the United States, according to some studies.

Ziyad Al-Aly receives funding from U.S. Department of Veterans Affairs. A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his ...